Michael Oellerich

Michael Oellerich, MD, HonMD, FAACC, FAMM, FFPath (RCPI), FRCPath, is currently a Distinguished Research Professor at the Department of Clinical Pharmacology, University Medical Center Goettingen (UMG), and Chief Research Officer of the Liquid Biopsy Center GmbH (LBC), Goettingen, Germany. He was Chairman of the Department of Clinical Chemistry at UMG from 1991 to 2012, Dean of the Faculty of Medicine, and President of professional organizations (IATDMCT, DGLM, DGKL, WASPaLM). He currently is Associate Editor of the journal Therapeutic Drug Monitoring (TDM), and Co-Editor of a Special Collection of The Journal of Applied Laboratory Medicine (JALM) on “Value of laboratory testing and the value proposition”. He was Editor-in-Chief of the TDM journal (2003-2018), Associate Editor of Clinical Biochemistry (1996-2007) and Clinical Chemistry (2007-2013). His current research interests are in the field of cfDNA in cancer and transplantation. He authored more than 470 publications and received various awards (e.g. Ludolf-Krehl Award, IATDMCT Charles Pippenger Award, WASPaLM Medal of Honor, WASPaLM Gold-Headed Cane, BSCL Sign of Honor).